Predictions
Biodexa Pharmaceuticals Plc
Start price
Target price
Perf. (%)
€1.43
26.04.24
26.04.24
-
26.04.25
26.04.25
-14.69%
26.04.24
26.04.24
Mersana Therapeutics
Start price
Target price
Perf. (%)
€2.68
24.04.24
24.04.24
-
24.04.25
24.04.25
2.01%
26.04.24
26.04.24
Could be worthwhile Investment >10% per year
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.49
23.04.24
23.04.24
€3.00
23.04.25
23.04.25
-9.36%
01:00
01:00
Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€7.07
15.04.24
15.04.24
-
15.04.25
15.04.25
-6.99%
01:00
01:00
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.24
15.04.24
15.04.24
-
12.04.25
12.04.25
12.90%
18.04.24
18.04.24
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.81
15.04.24
15.04.24
€3.00
31.10.25
31.10.25
-
15.04.24
15.04.24
Could be very worthwhile Investment >20% year
Delticom AG
Start price
Target price
Perf. (%)
€2.06
15.04.24
15.04.24
-
15.04.25
15.04.25
21.36%
01:00
01:00
High valuation
Probably not worthwhile Investment
Low dividend yield expected
negative Cash Flow expected
Fair Value Reit-Ag
Start price
Target price
Perf. (%)
€3.66
15.04.24
15.04.24
-
15.04.25
15.04.25
2.73%
01:00
01:00
Medium risks for its business
negative Cash Flow expected
EBIT decline/stagnation expected
Increased challenges to pay loans and raise capital
Liquidia Technologies Inc
Start price
Target price
Perf. (%)
€13.78
13.04.24
13.04.24
€12.00
13.04.25
13.04.25
-15.09%
01:00
01:00
Probably not worthwhile Investment
EBIT decline/stagnation expected
Low dividend yield expected
Revenue decline/stagnation expected
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.07
13.04.24
13.04.24
€1.00
13.04.25
13.04.25
-6.54%
01:00
01:00
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.51
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-9.27%
01:00
01:00
negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.48
12.04.24
12.04.24
-
12.04.25
12.04.25
-16.22%
15.04.24
15.04.24
Deutsche Rohstoff AG
Start price
Target price
Perf. (%)
€40.70
12.04.24
12.04.24
€42.00
12.04.25
12.04.25
6.14%
24.04.24
24.04.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Rising EBIT margin expected
Fair valuation